Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats
Nutrients · 2025
DOI: 10.3390/nu17193066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Sergio Martínez-Ruiz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Extracellular Vesicles, Escherichia coli, Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MICIU/AEI/ 10.13039/501100011033, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Background
The gut-liver axis is essential for maintaining liver physiology, with the gut microbiota playing a central role in this bidirectional communication. Recent studies have identified microbiota-derived extracellular vesicles (EVs) as key mediators of inter-organ signaling. This study explored the impact of EVs from two beneficial Escherichia coli strains, the probiotic EcN and the commensal EcoR12, on hepatic metabolism and oxidative stress in healthy neonatal rats.
Methods
EVs were administered orally during the first 16 days of life, and blood and liver samples were collected on days 8 and 16.
Results
The results demonstrated that EVs significantly reduced intestinal permeability, as evidenced by decreased plasma zonulin levels. In the liver, EVs enhanced redox homeostasis by downregulating CYP2E1 and upregulating key antioxidant genes (SOD1, CAT, GPX). Furthermore, the treatment shifted liver metabolism toward an anti-lipogenic profile by inducing fatty acid oxidation genes (PPARA, CPT1A) and suppressing genes involved in de novo lipogenesis (SREBP1C, ACC1, FASN, CNR1). Importantly, markers of hepatic inflammation remained unchanged, indicating the safety of the intervention. In vitro experiments using human HepG2 cells supported these findings, further validating the antioxidant and metabolic effects of the EVs.
Conclusions
Our results underscore the role of microbiota-derived EVs as important mediators of hepatic metabolic programming in healthy individuals via the gut-liver axis and highlight their potential as therapeutic postbiotic agents for management of fatty liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain.
- Institut de Biomedicina de la Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.
- Microbiota Intestinal, Institut de Recerca Sant Joan de Déu (IRSJD), Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain.
ORCID-Profile: Sergio Martínez-Ruiz, Josefa Badia, Laura Baldoma
Förderung
- MICIU/AEI/ 10.13039/501100011033
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Martínez-Ruiz, S., Badia, J., & Baldoma, L. (2025). Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats. Nutrients. https://doi.org/10.3390/nu17193066
Vancouver
Martínez-Ruiz S, Badia J, Baldoma L. Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats. Nutrients. 2025. doi:10.3390/nu17193066
BibTeX
@article{MartnezRuiz2025,
author = {Martínez-Ruiz, Sergio and Badia, Josefa and Baldoma, Laura},
title = {Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17193066}
}
EUVIMED